GSK India Head Admits Firm Seeking New Partners
This article was originally published in PharmAsia News
Executive Summary
India's GlaxoSmithKline Pharmaceuticals acknowledges it is on the lookout for local acquisitions to take advantage of its huge cash surplus. GSK India Senior Executive Director Mernosh Kapadia said the firm seeks to expand its India business, partially confirming the rumored interest in its parent GSK to acquire India's Piramal. GSK India already is the largest foreign-owned drug maker in India, so its acquisition plans are of great interest. (Click here for more